Healthcare practices are witnessing change over the past few years. Combination therapy is a treatment practice that uses combination of two or more therapies focused of providing more effectiveness and good results.
Developing healthcare regulatory scenario, rapid advancements in medical devices and rising demand for advanced minimally invasive therapies are major factors expected to drive the growth of global aesthetics combination therapy market. Consumer spending on beautification especially among women’s is increasing. Demand for hair removal solutions/treatment is witnessing high rise. According to U.S. Census data and Simmons National Consumer Survey (NHCS) in the US 1.99 million consumers used hair removal treatment other than waxing 4 or more times in 2020. In 2011, according to The American Society for Dermatologic Surgery (ASDS) nearly 100,000 tattoo removal procedures were performed by doctors. That was up from the procedures performed in 2010 i.e. 86,000. From 2012 to 2013, the number of tattoo removals increased by 52%. Consumers approach towards adoption of simply invasive therapies is gaining traction. Major players are investing high for the business development their approach towards new product development and business partnership is expected to augment the growth of aesthetics combination therapy market.
In 2021, Allergan Aesthetics, a global player in providing aesthetic treatments acquired Soliton. The acquisition is expected to help company expands and complements Allergan Aesthetics' Body Contouring treatment portfolio and increase the customer base.
In 2020, Aesthetics Biomedical Inc., a global player in aesthetic products and devices partnered with SkinCeuticals with the focus to develop new minimally-invasive skin rejuvenation treatments. This partnership is expected to help the company enhance the business and increase the revenue share.
In 2019, Merz Launches, a global players engaged in providing medical solutions launched Belotero Revive, a dermal filler. The product launch is expected to help company enhance the product offering and enhance the business revenue.
Players approach towards enhancing the business in emerging economies in order to track the untapped market is expected to support the revenue growth of target market. Factors such as stringent government regulations related to product approval and lack of reimbursement policies are expected to hamper the growth of global aesthetics combination therapy market. In addition, lack of developed infrastructure in developing countries for the adoption of advanced devices is expected to challenge the growth of target market. However, high investment by major players for R&D activities and high spending by the government on strengthening the infrastructure of hospital to facilitate the new services are factors expected to create new opportunities for players operating in the aesthetics combination therapy market over the forecast period. In addition, increasing partnership between regional and international players is expected to support the revenue growth of target market.
Segment Analysis by Region
The market in North America is expected to account for major revenue share in the global aesthetics combination therapy market due to high consumer spending on skin treatment. Availability of advanced infrastructure and favorable reimbursement policies is expected to segment the regional market growth. In addition, players approach towards business enlargement is expected to support the market growth.
The market in Asia Pacific is expected to witness faster growth in the target market due to chancing government healthcare standards. High government spending on healthcare sector, rising awareness among consumers related to various therapies, and high spending capacity are factors expected to segment the growth of aesthetics combination therapy regional market.
The global aesthetics combination therapy market is highly competitive due to presence of large number of players and innovative product offerings. In addition, business expansion activities through partnerships and agreements are factors expected to further increase the competition.
Global Aesthetics Combination Therapy Market
2017 – 2028
2021 – 2028
Therapy Type, Application End Use and Geography
North America, Europe, Asia Pacific, Latin America, and Middle East & Africa
Market Trends, Drivers, Restraints, Competitive Analysis, Player Profiling, Regulation Analysis
Aesthetics Combination Therapy Market Segment Analysis, 2019
Te global aesthetics combination therapy market is segmented into therapy type, application and end use. The therapy type segment is divided into BTx-A/Dermal filler, BTx-A/Laser, laser/topical drug, laser/radiofrequency, dermal filler/topical drug, and others. Among therapy type the BTx-A/Laser segment is expected to account for significant revenue share in the global market. The application segment is bifurcated into hair removal, tattoo removal, skin resurfacing, scar removal, and others. Among application the hair removal segment is expected to account for significant revenue share in the target market. The players operating in the global aesthetics combination therapy market are Alma Lasers Ltd., Lumenis Ltd., Cynosure Inc., Valeant Pharmaceutical International, Inc., Galderma S.A., Anika Therapeutics, Inc., Speciality European Pharma, Merz Pharma GmbH & Co. KGaA, Cutera, Inc, Allergan, and Syneron Medical Ltd.
Market By Therapy Type
Dermal Filler/Topical Drug
Market By Application
Market By End Use
Ambulatory Surgical Centers
Market By Geography
• Rest of Europe
• South Korea
• Rest of Asia-Pacific
• Rest of Latin America
Middle East & Africa
• South Africa
• Rest of Middle East & Africa
Developing healthcare regulatory scenario, rapid advancements in medical devices and rising demand for advanced minimally invasive therapies are major factors expected to drive the growth of global aesthetics combination therapy market.
In application the hair removal segment is growing at faster pace.
In the global market the Asia Pacific region is expected to grow faster.
Some of the players considered in the report scope are Alma Lasers Ltd., Lumenis Ltd., Cynosure Inc., Valeant Pharmaceutical International, Inc., and Galderma S.A.
The North America is expected to account for major revenue share in the global market.
Factors such as stringent government regulations related to product approval and lack of reimbursement policies are expected to hamper the growth of global aesthetics combination therapy market.